COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

NCT04397757 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Pennsylvania